Cite
HARVARD Citation
Tada, T. et al. (2022). Glasgow prognostic score predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib: a multicenter analysis. European journal of gastroenterology & hepatology. 34 (8), pp. 857-864. [Online].